Neuropsychiatry of Huntington's disease

Dialogues in Clinical Neuroscience

Volumn 9, Issue 2, 2007, Pages 191-197

  Rosenblatt, Adam ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Chorea; Dementia; Executive; Frontal; Huntington's disease; Neurodegenerative; Neuropsychiatry; Subcortical

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; METHYLPHENIDATE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGITATION; APATHY; ARTICLE; AUDITORY HALLUCINATION; BEHAVIOR DISORDER; BIPOLAR DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; DELIRIUM; DELUSION; DEMENTIA; DEPRESSION; DYSPHORIA; DYSTONIA; ELECTROCONVULSIVE THERAPY; GLUCOSE METABOLISM; HUMAN; HUNTINGTON CHOREA; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; RATING SCALE; SLEEP DISORDER; SYMPTOMATOLOGY;

AGGRESSION; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; FRONTAL LOBE; HUMANS; HUNTINGTON DISEASE; IMPULSIVE BEHAVIOR; MENTAL DISORDERS; MOOD DISORDERS; SOCIAL BEHAVIOR DISORDERS;

EID: 34447579898     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Brandt J, Shpritz B, Codori AM, Margolis R, Rosenblatt A. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. J Int Neuropsychol Soc. 2002;8:918-924.
2. Duff K, Paulsen JS, Beglinger, LJ, Langbehn DR, Stout JC, and the Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington's disease before diagnosis: The Predict-HD Study. Biol Psychiatry. In press.
3. Lyketsos CG, Rosenblatt A, Rabins PV. Forgotten frontal lobe syndrome or "executive dysfunction syndrome." Psychosomatics. 2004;45:247-255.
4. Arango-Lasprilla JC, Rogers H, Lengenfelder J, Deluca J, Moreno S, Lopera F. Cortical and subcortical diseases: do true neuropsychological differences exist? Arch Clin Neuropsychol. 2006;21:29-40.
5. Brandt J, Folstein SE, Folstein MF Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Ann Neurol. 1988;23:555-561.
6. Burns A, Folstein S, Brandt J, Folstein M. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Ment Dis. 1990;178:20-26.
7. Huntington G. On chorea. Medical and Surgical Reports of Philadelphia. 1872;26:317-321.
8. Folstein SE, Chase G, Wahl W, McDonnel AM, Folstein MF. Huntington's disease in Maryland: clinical aspects of racial variation. Am J Hum Genet. 1987;41:168-179.
9. Shiwach R. Psychopathology in Huntington's disease in patients. Acta Psychiatr Scand. 1994;90:241-246.
10. Shoenfield M, Myers RH, Cupples RA, Berkman B, Sax DS, Clark E. Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 1984;47:1283-1287.
11. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry. 2001;71;310-314
12. Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington's disease. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:219-226.
13. Mayberg HS, Starkstein SE, Peyser CE, et al. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology. 1992;42:1791-1797.
14. Baxter LR, Mazziotta JC, Pahl JJ, et al. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry. 1992;49:148-152.
15. Guttman, M, Alpay, M, Chouinard, et al. Clinical management of psychosis and mood disorders in Huntington's disease. In: Mental and Behavioral Dysfunction in Movement Disorders. Totowa, NJ: Humana; 2002:409-426.
16. Ranen NG, Peyser CE, Folstein SE. ECT as a treatment for depression in Huntington's disease. J Neuropsychol. 1994;6:154-158.
17. Mendez MF. Huntington's disease: update and review of neuropsychiatric aspects. Int J Psychiatry Med. 1994;24:189-208.
18. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
19. Marder K, Zhao H, Myers R, et al. (Huntington Study Group): Rate of functional decline in Huntington's disease. Neurology. 2000;54:452-458; correction, 54:1712.
20. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord. 1996;11:136-142.
21. Anderson K, Louis ED, Stern Y, Marder KS Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. Am J Psychiatry. 2001;158:799-801.
22. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
23. Cummings JL, Cunningham K. Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry. 1992;31:263-270.
24. Rauch SL, Whalen PJ, Dougherty D, Jenike MA. Neurobiologic models of obsessive-compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Practical Management. 3rd ed. St Louis, Minn: Mosby; 1998:222-317.
25. Thompson JC, Snowden JS, Craufurd D, Neary D. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci. 2002;14:37-43.
26. Rosenblatt A, Leroi I. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics. 2000;41:24-30.
27. Rosenblatt A, Anderson, K, Goumeniouk AD, et al. Clinical management of aggression and frontal syndromes in Huntington's disease. In: Mental and Behavioral Dysfunction in Movement Disorders. Totowa, NJ: Humana; 2002:427-441.
28. Kertesz, A, Nadkarni N, Davidson W, Thoma AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J International Neuropsychological Society. 2000;6:460-468.
29. Marin RS Fogel BS., Hawkins J, Duffy J, Krupp B. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci. 1995;7:23-30.
30. Shoulson, I. Huntington's disease: cognitive and psychiatric features. Neuropsychiatry Neuropsychol Behav Neurol. 1990;3:15-22.
31. Drayton SJ, Davies K, Steinberg M, Leroi I, Rosenblatt A, Lyketsos CG. Amantadine for executive dysfunction syndrome in patients with dementia. Psychosomatics. 2004;45:205-209.
32. Hoth KF, Paulsen JS, Moser DJ, Tranel D, Clark LA, Bechara A. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol. In press.
33. Fedoroff JP, Peyser C, Franz ML, et al: Sexual disorders in Huntington's disease. J Neuropsychiatry Clin Neurosci. 1994;6:147-153.
34. McAllister TW. Apathy. Sem Clin Neuropsychiatry. 2000;5:275-282.